title: Nelfinavir (Viracept) moves up the ranks.
authors.forename: B
authors.initials: B
authors.lastname: Grodeck
mesh_terms: D000328:Adult; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D002648:Child; D017277:Drug Approval; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage* / Q000009:adverse effects; D019888:Nelfinavir; D013451:Sulfonic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D013451:Sulfonic Acids; D019888:Nelfinavir